Augmented Care at Worksite for Diabetes Prevention
Status: | Recruiting |
---|---|
Conditions: | Diabetes |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 21 - Any |
Updated: | 4/17/2018 |
Start Date: | February 8, 2018 |
End Date: | December 2023 |
Contact: | Carla Miller, Ph.D. |
Email: | miller.4453@osu.edu |
Phone: | 614-292-1391 |
Impact of Augmented Care at the Worksite for Diabetes Prevention
The purpose of the study is to evaluate the impact of augmented care at the worksite through
a lifestyle intervention for diabetes prevention among employees with prediabetes who are
slower to respond to a standard diabetes prevention intervention.
a lifestyle intervention for diabetes prevention among employees with prediabetes who are
slower to respond to a standard diabetes prevention intervention.
Employees at The Ohio State University (OSU) with prediabetes will participate in a standard
lifestyle intervention for diabetes prevention. Participants who do not achieve >2.5% weight
loss by week 5 of the intervention will transition into augmented care with an enhanced
training program that addresses values clarification, decision making, planning, and problem
solving. The impact of the enhanced intervention will be evaluated at 4, 12 and 18 months
from baseline to determine if implementing early enhanced training helps participants achieve
and maintain weight loss similar to those who received the standard intervention.
lifestyle intervention for diabetes prevention. Participants who do not achieve >2.5% weight
loss by week 5 of the intervention will transition into augmented care with an enhanced
training program that addresses values clarification, decision making, planning, and problem
solving. The impact of the enhanced intervention will be evaluated at 4, 12 and 18 months
from baseline to determine if implementing early enhanced training helps participants achieve
and maintain weight loss similar to those who received the standard intervention.
Inclusion Criteria:
1. Benefits-eligible Ohio State University employee
2. Intend to be employed by OSU through the length of the follow-up phase
3. Body mass index: >24 kg/m2 non-Asians; >22 kg/m2 Asians
4. American Diabetes Association risk score of ≥ 5
5. Fasting blood glucose of 100-125 mg/dL
6. Blood glucose of 110-199 (if non-fasting in previous 2 hours)
Exclusion Criteria:
1. Blood glucose level of ≥ 200 mg/dL
2. Conditions that would limit adoption of light/moderate physical activity (i.e.,
cardiac event, severe chronic obstructive pulmonary disease, advanced arthritis,
poorly controlled hypertension)
3. Chronic use of medications that affect blood glucose levels (i.e., corticosteroids)
4. Concurrent participation in a structured weight loss program or counseling for
bariatric surgery
5. Pregnant or breastfeeding
6. Score of ≥ 10 on the Patient Health Questionnaire-8 indicating moderate to severe
depressive symptoms
7. Score of ≥ 27 on the Binge Eating Scale
8. Unwilling to accept randomization
9. Planning to move from the area or changing employment.
We found this trial at
1
site
Ohio State University The Ohio State University’s main Columbus campus is one of America’s largest...
Click here to add this to my saved trials